publication date: Dec. 22, 2010
In this issue:
As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move;
ASCO, NCCS Call For Oncology Center;
Zerhouni Appoints Two Institute Directors;
ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard;
NCI Program Develops Bioinformatics Tool To Design Cancer Drugs;
Download (PDF 206KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.